Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV

Weight and body mass index (BMI) change was assessed among women after switch to integrase inhibitors (INSTIs) and/or tenofovir alafenamide (TAF). From 2006 to 2019, 1,458 women living with HIV enrolled in the Women's Interagency HIV Study and on antiretroviral therapy (ART) with ≥1 study visit...

詳細記述

保存先:
書誌詳細
出版年:AIDS Res Hum Retroviruses
主要な著者: Lahiri, Cecile D., Xu, Yanxun, Wang, Kunbo, Alvarez, Jessica A., Sheth, Anandi N., O'Halloran, Jane, Spence, Amanda B., Tien, Phyllis, Gustafson, Deborah R., Milam, Joel, Fischl, Margaret A., Konkle-Parker, Deborah, Adimora, Adaora A., Sharma, Anjali, Weber, Kathleen M., Ofotokun, Igho, Rubin, Leah H.
フォーマット: Artigo
言語:Inglês
出版事項: Mary Ann Liebert, Inc., publishers 2021
主題:
Epidemiology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8213005/
https://ncbi.nlm.nih.gov/pubmed/33231474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2020.0197
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料